Feedback / Questions
IkT-148009 - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-reports-third-quarter-2022-financial-results-and-highlights-recent-period-activity-301677620.html#:~:text=Net%20loss%20for%20the%20nine,the%20comparable%20period%20in%202021.
Nov 14, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next